Glycomine

0 followers

‌

Glycomine is developing orphan drugs for serious rare disorders of metabolism and protein misfolding for which no other therapeutic options exist.

Industries

Biotechnology

Headquarters

San Carlos, United States

Employees

11-50

Links

Org chart

Steven Axon

Director & CEO

Steven Axon

Collapse

Hicham Alaoui

Chief Scientific Officer

Geoffrey Hird

Chief Technology Officer

Peter McWilliams

Chief Business Officer

Kerryn Mccluskie

VP, Non-clinical Development

Lisa Koch-Hulle

Acting VP, Regulatory Affairs

Drew Folk

Sr. Director Of Product Development

Emily Tess

Chief of Staff, Director of Corporate Development & Strategy

Kevin Herlihy

Sr. Director Manufacturing Science And Technology

Colette Muenzen

Senior Legal Consultant

Rose Marino

Chief Medical Officer

Teams

+10

Directors

13 members

Leadership Team

3 members

Clinical and Regulatory

4 members

Similar companies

Immunome

2 followers

Thermo Fisher Scientific

155 followers

BeiGene

19 followers

Cytiva

10 followers

Merck

211 followers

Tessera Therapeutics

2 followers

Vial

5 followers

Ventyx Biosciences

1 follower

Pyxis Oncology

1 follower

Mineralys Therapeutics

1 follower

Thrive Capital

26 followers

Explore companies